Search
Patexia Community

Innovation, Technology, and IP News

Patent Affirmed as Unenforceable Due to Prosecution Laches

Written by: Daniel Kiang & Timothy A. Willis PERSONALIZED MEDIA COMMUNICATIONS, LLC V. APPLE INC. Before Reyna, Chen, and Stark. Appeal from the United States...

A Look At The Legal Intersection Of AI And Life Sciences

By Ariel Soiffer, Elijah Soko and Paul Lekas (January 20, 2023) This article was not written by ChatGPT. Will all articles have to start with a statement like this? And will any...

Patexia Insight 166: 5-Year Patent Litigation Trends

Tomorrow, our third annual Patent Litigation Intelligence Report will be released, covering the period from July 1, 2017, through June 30, 2022. The report evaluated a total of 18,493...

Is a Patent a Definitive Assurance of Your Idea's Authenticity?

A patent is a legal form of protection granted to inventors for their unique and useful ideas, designs, or products. It gives the patent owner exclusive rights to prevent others from...

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Personalized Media Communications, LLC v. Apple, Inc., Appeal No. 2021-2275 (Fed. Cir. Jan. 20, 2023) Our Case of the Week focuses on the doctrine of prosecution...

BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda

Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in Mainz, Germany, is scheduled to ship...

Feed tagged as "biotech":
  Small molecule drugs have been the norm for much of medicine’s history. Only in the past decade has there been a rise ... Read More »
BAXALTA INC. V. GENENTECH, INC. Before Moore, Plager, and Wallach.  Appeal from the District of Delaware Summary: A district court erred by interpreting... Read More »
BAXALTA INC. V. GENENTECH, INC. Before Moore, Plager, and Wallach.  Appeal from the District of Delaware Summary: A district court erred by interpreting... Read More »
ILLUMINA, INC. v. ARIOSA DIAGNOSTICS, INC. Before Lourie, Moore, and Reyna. Modified opinion following Ariosa rehearing petition. Summary: The Federal Circuit ... Read More »
In recent years, market interest in meat substitutes has aligned with advances in cell culture techniques to support the emergence of lab-grown meat or... Read More »
Until the cloning of Dolly the sheep in 1996 by scientists at the Roslin Institute, the idea of cloning a mammal, let alone a human being, was an idea relegated to... Read More »
On May 14, 2018, several important revisions to regulations of the Bayh-Dole Act (University and Small Business Patent Procedure Act of 1980, codified as 35 U.S.C... Read More »
In vitro gametogenesis (IVG) is a recent development in reproductive technology, and has been used for creating mouse embryos in vitro. IVG includes obtaining cells... Read More »
A new infertility technique, mitochondrial replacement therapy (MRT), has been used to create so called “three-parent” babies. MRT is used in cases when... Read More »
Lundbeck Pharmaceutical Company, headquartered in Denmark, recently announced the acquisition of Prexton Therapeutics B.V. for $1.1 billion (U.S.)(1).  Lundbeck... Read More »
On March 6, 2018, 23andMe, Inc. received the first-ever FDA authorization for a direct-to-consumer genetic test that analyzes gene mutations to help predict a... Read More »
On February 14, 2018, the U.S. Food and Drug Administration (FDA) approved Janssen Therapeutics’ Erleada (apalutamide), a non-steroidal antiandrogen for the... Read More »
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s... Read More »
In an effort to lay the groundwork for generic entry and reduced drug prices, the non-profit group Initiative for Medicines, Access and Knowledge, Inc. (I-MAK), with... Read More »
Written by Daniel A. Kamkar and Michael L. Fuller On October 9, 2017, California Governor Jerry Brown signed the new drug price transparency bill SB 17.[1]   ... Read More »
Written by Scott Siera, Ph.D. and Eric Furman, Ph.D. Seven years after Mylotarg® (gemtuzumab ozogamicin) was voluntarily withdrawn from the market, the U.S... Read More »
Written by Daniel A. Kamkar and Agnes Juang, Ph.D. On August 2, 2017, the U.S. Food and Drug Administration approved the use of Imbruvica® (ibrutinib) for the ... Read More »
Written by Marc Chatenay-Lapointe, Ph.D. and Jason Jardine On July 13, 2017, the U.S. Food and Drug Administration approved Tremfya (guselkumab), a biologic... Read More »
Written by Scott Siera, Ph.D. and Michael L. Fuller Stanford University v. The Chinese University of Hong Kong. Federal Circuit Appeal No. 2015-2011. Decided June ... Read More »
Written by Jeffrey C. Wu, Ph.D. and Brenden S. Gingrich, Ph.D. New York City took a step toward its goal of becoming a life sciences hub with a $5 million grant... Read More »
Show more Newsfeed posts
Menu